412.62  -4.05 (-0.97%)		10-30 16:00
Open: 420.25 High: 422.08 Volume: 1,062,314		Pre. Close: 416.67 Low: 407.67 Market Cap: 28,744(M)

Short term
Mid term
Targets	6-month :	511.75	1-year :	597.73
Resists	First :	438.14	Second :	511.75
Pivot price	390.62
Supports	First :	389.53	Second :	359.48
MAs	MA(5) :	405.19	MA(20) :	385.22
	MA(100) :	357.4	MA(250) :	305.08
MACD	MACD :	11.7	Signal :	9.1
%K %D	K(14,3) :	78.3	D(3) :	88
RSI	RSI(14): 75.3
52-week	High :	438.14	Low :	223.51

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ WST ] has closed below upper band by 9.2%. Bollinger Bands are 69% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	422.42 - 424.55	424.55 - 425.92
Low:	402.63 - 405.43	405.43 - 407.22
Close:	408.58 - 412.83	412.83 - 415.55

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Sat, 31 Oct 2026
WST Q3 deep dive: Biologics and regulatory tailwinds fuel margin expansion, HVP mix shift continues - Yahoo Finance

Sat, 31 Oct 2026
What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call - Yahoo Finance

Fri, 30 Oct 2026
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $470, Implies 13% Upside - TradingView

Thu, 29 Oct 2026
A Look at West Pharmaceutical Services Inc (WST) After 3.2% Gain -- GF Value $360.50 vs Price $416.67 - GuruFocus

Thu, 29 Oct 2026
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $427.57, Implies 6% Upside - TradingView

Thu, 29 Oct 2026
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	70 (M)
Shares Float	70 (M)
Held by Insiders	0.6 (%)
Held by Institutions	102.1 (%)
Shares Short	2,100 (K)
Shares Short P.Month	2,200 (K)

EPS	7.8
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	42.47
Profit Margin	16.9 %
Operating Margin	22.4 %
Return on Assets (ttm)	11.3 %
Return on Equity (ttm)	19 %
Qtrly Rev. Growth	13.8 %
Gross Profit (p.s.)	17.33
Sales Per Share	47.31
EBITDA (p.s.)	12.96
Qtrly Earnings Growth	18.1 %
Operating Cash Flow	662 (M)
Levered Free Cash Flow	278 (M)

PE Ratio	52.83
PEG Ratio	3
Price to Book value	9.71
Price to Sales	8.72
Price to Cash Flow	43.85

Dividend	0.21
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.